
|Videos|August 4, 2021
From Drug Substance to Drug Product: Integrated Solid Form Selection
Author(s)Lonza
What are some effective strategies for compressing development timelines and derisking the process along the way? The PharmTech-Lonza Tech Talks Series on Integrated Services includes a 12-minute discussion of integrated drug substance form selection and optimization to drug product with Michael Grass, PhD, head of solid form services at Lonza.
Trending on Pharmaceutical Technology
1
PharmTech Weekly Roundup—June 5, 2026
2
Renewing Prosaic Generics for Cancer Treatment
3
Tom Sellig on CDMO Innovation and US Manufacturing Growth
4
Faster Doesn’t Mean Easier: Development Impacts of a New Biosimilar Regulatory Landscape
5




